menu
    • menu

    Company profile for Formosa Pharmaceuticals

    NEW Drugs in Dev: 3
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Formosa Pharmaceuticals, founded in 2010, is a late-preclinical and early-clinical stage biopharmaceutical company with focus in the indications of ophthalmology, oncology, and anti-infectives. In August, 2017, Formosa Pharmaceuticals acquired Activus Pharmaceuticals (Funabashi, Japan), which afforded Formosa Pharmaceuticals a proprietary nanoparticle technology platform (APNT), and two late-stage preclinical assets in ophtha...
    Formosa Pharmaceuticals, founded in 2010, is a late-preclinical and early-clinical stage biopharmaceutical company with focus in the indications of ophthalmology, oncology, and anti-infectives. In August, 2017, Formosa Pharmaceuticals acquired Activus Pharmaceuticals (Funabashi, Japan), which afforded Formosa Pharmaceuticals a proprietary nanoparticle technology platform (APNT), and two late-stage preclinical assets in ophthalmology. Of these ophthalmology candidates, APP13007 has just begun Phase 3 clinical trials in the United States for inflammation and pain after ocular surgery.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Formosa PharmaceuticalsTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    8F-6, No.57, Fuxing N. Rd, Songshan Dist,Taipei City105
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.formosapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/formosa-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arab Health

    Arab Health

    Not Confirmed

    envelop Contact Supplier

    Arab Health

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Formosa, Samil Pharma Ink Clobetasol Ophthalmic Drug Deal
    Formosa, Samil Pharma Ink Clobetasol Ophthalmic Drug Deal

    12 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-announces-licensing-agreement-with-samil-pharmaceuticals-co-ltd-for-commercialization-of-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-inflammation-and-pain-following-ocular-surgery-302658104.html

    PR NEWSWIRE
    12 Jan 2026
    Share Share
    Formosa Licenses Clobetasol Ophthalmic Suspension to Rxilient
    Formosa Licenses Clobetasol Ophthalmic Suspension to Rxilient

    03 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-announces-licensing-agreement-with-rxilient-for-commercialization-of-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-inflammation-and-pain-following-ocular-surgery-302631552.html

    PR NEWSWIRE
    03 Dec 2025
    Share Share
    Harrow Acquires US Commercial Rights to Byqlovi from Formosa
    Harrow Acquires US Commercial Rights to Byqlovi from Formosa

    10 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250609515264/en/Harrow-Acquires-U.S.-Commercial-Rights-to-BYQLOVI-Clobetasol-Propionate-Ophthalmic-Suspension-0.05-from-Formosa-Pharmaceuticals

    BUSINESSWIRE
    10 Jun 2025
    Share Share
    Formosa, Adalvo License Clobetasol For Eye Conditions
    Formosa, Adalvo License Clobetasol For Eye Conditions

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-adalvo-limited-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-ocular-inflammation-and-pain-302465602.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex
    Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-announces-licensing-agreement-with-apotex-inc-for-commercialization-of-clobetasol-propionate-ophthalmic-suspension-for-post-ocular-surgery-inflammation-and-pain-for-mexico-302447818.html

    PR NEWSWIRE
    06 May 2025
    Share Share
    Formosa Pharma and Almac Discovery License ALM-401 in Solid Tumor
    Formosa Pharma and Almac Discovery License ALM-401 in Solid Tumor

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-almac-discovery-announce-licensing-agreement-for-alm-401-a-first-in-class-bispecific-adc-targeting-egfrror1-for-the-treatment-of-solid-tumors-302447143.html

    PR NEWSWIRE
    06 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search